Read + Share
Arai J, Otoyama Y, Fujita KI, Goto K, et al. Baseline soluble MICA levels act as a predictive biomarker for the efficacy of
regorafenib treatment in colorectal cancer. BMC Cancer 2022;22:428.
PMID: 35443621
|
 |
|
Arai J, Otoyama Y, Fujita KI, Goto K, et al. Baseline soluble MICA levels act as a predictive biomarker for the efficacy of
regorafenib treatment in colorectal cancer. BMC Cancer 2022;22:428.
PMID: 35443621
|
|
|
|